X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (83) 83
cardiac & cardiovascular systems (45) 45
humans (45) 45
index medicus (44) 44
cardiology and cardiovascular medicine (42) 42
heart attacks (38) 38
abridged index medicus (36) 36
female (31) 31
internal medicine (31) 31
stents (30) 30
cardiology (29) 29
male (29) 29
aged (27) 27
middle aged (25) 25
mortality (25) 25
stent (24) 24
percutaneous coronary intervention (23) 23
thrombosis (22) 22
acute coronary syndromes (21) 21
drug-eluting stents (21) 21
transluminal angioplasty (21) 21
treatment outcome (20) 20
cardiac patients (19) 19
clopidogrel (19) 19
coronary heart disease (19) 19
coronary vessels (18) 18
care and treatment (17) 17
implantation (16) 16
patients (16) 16
cardiovascular disease (15) 15
aspirin (14) 14
clinical trials (14) 14
follow-up studies (14) 14
studies (14) 14
analysis (13) 13
clinical outcomes (13) 13
intervention (13) 13
platelet aggregation inhibitors - administration & dosage (13) 13
bleeding (12) 12
patient outcomes (12) 12
drug therapy (11) 11
medicine, general & internal (11) 11
myocardial infarction (11) 11
outcomes (11) 11
stroke (11) 11
anticoagulants (10) 10
drug-eluting stent (10) 10
heart attack (10) 10
metaanalysis (10) 10
randomized controlled trials as topic (10) 10
risk assessment (10) 10
ticlopidine - analogs & derivatives (10) 10
acute myocardial-infarction (9) 9
electrocardiography (9) 9
percutaneous coronary intervention - methods (9) 9
platelet aggregation inhibitors - adverse effects (9) 9
revascularization (9) 9
time factors (9) 9
coronary angiography (8) 8
efficacy (8) 8
medical research (8) 8
myocardial-infarction (8) 8
risk (8) 8
safety (8) 8
stent thrombosis (8) 8
therapy (8) 8
ticlopidine - administration & dosage (8) 8
aged, 80 and over (7) 7
angioplasty (7) 7
angioplasty, balloon, coronary (7) 7
aspirin - administration & dosage (7) 7
comparative analysis (7) 7
coronary artery bypass (7) 7
coronary artery disease (7) 7
medical colleges (7) 7
medicine, experimental (7) 7
randomization (7) 7
registry (7) 7
trial (7) 7
acute coronary syndrome - diagnosis (6) 6
acute coronary syndrome - surgery (6) 6
angina pectoris (6) 6
angiography (6) 6
diabetes (6) 6
drug therapy, combination (6) 6
elevation myocardial-infarction (6) 6
heart (6) 6
heart diseases (6) 6
hemorrhage - chemically induced (6) 6
implants (6) 6
ischemia (6) 6
medical and health sciences (6) 6
medicin och hälsovetenskap (6) 6
myocardial infarction - etiology (6) 6
myocardial infarction - therapy (6) 6
percutaneous coronary intervention - adverse effects (6) 6
platelet aggregation inhibitors - therapeutic use (6) 6
prognosis (6) 6
proportional hazards models (6) 6
risk factors (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 13, pp. 1321 - 1323
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 12, pp. 1211 - 1214
Corresponding Author 
Cardiovascular
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 9, pp. 980 - 981
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 25, pp. 2702 - 2702
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2012, Volume 5, Issue 6, pp. 692 - 693
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 51, Issue 7, pp. 775 - 776
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 8, pp. 805 - 815
Abstract Background The use of drug-eluting stents (DES) in patients at high risk of bleeding or thrombosis has not been prospectively studied; limited data... 
Cardiovascular | Internal Medicine | dual-antiplatelet therapy | high bleeding risk | high thrombotic risk | zotarolimus-eluting stent(s) | drug-eluting stent(s) | dualantiplatelet therapy | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | OPTICAL COHERENCE TOMOGRAPHY | RANDOMIZED-TRIAL | IMPLANTATION | POLYMER | ACUTE MYOCARDIAL-INFARCTION | CORONARY-ARTERY STENTS | ST-SEGMENT ELEVATION | DURATION | Coronary Artery Disease - surgery | Humans | Immunosuppressive Agents - therapeutic use | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Risk Assessment | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnosis | Aged | Biocompatible Materials - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Sects | Stent (Surgery) | Heart attacks | Drug therapy | Stents | Coronary vessels
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 17, pp. 1851 - 1864
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 16, pp. 2011 - 2022
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 99, Issue 8, pp. 1072 - 1081
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 116, Issue 6, pp. 845 - 852
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 1, pp. 201 - 213
Abstract Objectives The aim of this meta-analysis was to compare the 30-day safety and efficacy of bivalirudin with those of heparin with or without routine... 
Cardiovascular | heparin | meta-analysis | GP IIb/IIIa inhibitor | acute coronary syndrome | bivalirudin | Bivalirudin | Heparin | Acute coronary syndrome | Meta-analysis | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | BARE-METAL STENTS | STRATEGY | RISK | TRIAL | OUTCOMES | INTERVENTION | ELEVATION MYOCARDIAL-INFARCTION | UNFRACTIONATED HEPARIN | PLUS | Recombinant Proteins - therapeutic use | Humans | Acute Coronary Syndrome - mortality | Heparin - therapeutic use | Recombinant Proteins - adverse effects | Heparin - adverse effects | Time Factors | Platelet Glycoprotein GPIIb-IIIa Complex - metabolism | Coronary Thrombosis - prevention & control | Blood Platelets - drug effects | Odds Ratio | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Risk Factors | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Chi-Square Distribution | Acute Coronary Syndrome - blood | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Randomized Controlled Trials as Topic | Acute Coronary Syndrome - drug therapy | Blood Platelets - metabolism | Hirudins - adverse effects | Acute Coronary Syndrome - diagnosis | Coronary Thrombosis - etiology | Myocardial Infarction - prevention & control | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced
Journal Article